Experiments demonstrate that artificial cannabinoids are associated with better prices of toxicity and medical center admissions than natural cannabis.These artificial cannabinoids tend to be marketed as “lawful highs,” and they are sold in vibrant packaging that appeals to young customers, which include herbal incense as K2 spice. Nevertheless